ESC 24: Hot Line & Late-breaking Science Video Collection
Published: 15 August 2024
-
Views:
2589
-
Likes:
7
-
Views:
2589
-
Likes:
7
-
Up Next -
17m 28sPart 3 | Session 5 FINEARTS-HF: Finerenone HFmEF & HFpEF
-
6m 8s -
5m 29sPart 4 | Session 2 MATTERHORN: M-TEER vs Surgery in Heart Failure -
5m 46sPart 4 | Session 3 MRAs in Heart Failure -
4m 24sPart 4 | Session 4 FINE-HEART: Finerenone in HF & CKD -
8m 18sPart 4 | Session 5 STEEER-AF: Stroke Prevention & Rhythm Control Therapy -
3m 52sPart 4 | Session 6 NOTION-3: FFR Guided PCI in TAVI -
6m 48sPart 4 | Session 7 EPIC-CAD: Edoxaban vs Dual Antiplatelet Therapy in AF & CAD -
8m 17sPart 4 | Session 8 SENIOR RITA: Invasive Vs Conservative Strategy for Older Patients with MI -
3m 51sPart 4 | Session 9 EARTH-STEMI: Complete Vs Culprit-Only Revascularization in Older Patients -
4m 17sPart 4 | Session 10 SCOFF: Fasting vs. Non-Fasting: Impact on Cardiac Catheterization Outcomes -
4m 17sPart 4 | Session 11 GUARD-AF: Atrial Fibrillation Screening to Reduce Stroke in Elderly Individuals -
2m 31s -
7m 9sPart 4 | Session 13 POPular PAUSE TAVI: Continuation or interruption of OAC During TAVI
-
4m 54sPart 5 | Session 1 3 Trials That Will Change My Practice With Dr Muthiah Vaduganathan -
13m 47sPart 5 | Session 2 3 Trials That Will Change My Practice With Dr Michelle Kittleson
-
6m 55sPart 6 | Session 1 New Guidelines for the Management of Atrial Fibrillation -
6m 13sPart 6 | Session 2 New Guidelines for the Management of Aortic Diseases
-
47m 31sPart 1 | Session 1 ESC Congress 2024 Hot Line Wrap Up Nicolas M Van Mieghem, Joost Daemen
-
27m 27sPart 1 | Session 2 ESC Congress 2024 Hot Line Preview Nicolas M Van Mieghem, Joost Daemen
-
17m 25sPart 2 | Session 1 ESC Day 1 Wrap Up: New Guidelines, HELIOS-B, ABYSS & STOP-or-NOT Mirvat Alasnag, Khaled Al-Shaibi
-
23m 2sPart 2 | Session 2 ESC Day 2 Wrap-Up: NOTION-3, RESHAPE-HF2, TRI.Fr & More Mirvat Alasnag, Khaled Al-Shaibi
-
12m 28sPart 2 | Session 3 Day 3 Wrap-Up with Dr Alasnag and Dr Al-Shaibi Mirvat Alasnag, Khaled Al-Shaibi
-
15m 45sPart 2 | Session 4 Day 4 Wrap-Up: OCCUPI, REC-CAGEFREE I, AEGIS-II & More Mirvat Alasnag, Khaled Al-Shaibi
-
20m 58sPart 3 | Session 1 AβYSS: Beta Blocker Interruption After Uncomplicated MI Harriette Van Spall, Prof. Johanne Silvain
-
20m 14sPart 3 | Session 2 RHEIA: TAVR vs SAVR in Women with Severe AS Helene Eltchaninoff, Harriette Van Spall
-
8m 47sPart 3 | Session 3 OCEANIC-AF: Asundexian Vs Apixaban in Atrial Fibrillation Manesh R Patel, Harriette Van Spall
Overview
What's hot at the ESC Congress 2024?
Stay ahead of the curve with our faculty-led coverage of the European Society of Cardiology Congress in London. From groundbreaking trials to expert insights, we've got you covered.
- Watch our View From the Thoraxcenter series for practice-focused reviews of the most anticipated trials from interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen.
- For a deeper dive into key hot line clinical trial data and its applicability, host, Dr Harriette Van Spall meets with principal investigators in her Late-Breaker Discussion series.
- View a condensed summary of the crucial takeaways from each day in our Wrap-Up series led by Dr Mirvat Alasnag.
- Our short, bite-sized Expert Interviews with select faculty will focus on data, take-home messages for practice and the future of their field.
Get ready for a deep dive into the latest cardiology research. Our coverage of the ESC Congress is coming soon.
More from this programme
Part 1
View From the Thoraxcenter: What's Hot at ESC 24?
Part 2
Daily Wrap Ups with Dr Alasnag and Dr Al-Shaibi
Part 3
Hot-line Discussions with Dr Harriette Van Spall
Part 4
Expert Interviews
Part 5
Highlights
Part 6
Guidelines
About the episode
ESC Congress 2024 — SWEDEGRAFT does not support the routine use of no-touch vein harvest compared to the standard technique.
Dr Harriette Van Spall (McMaster University, CA) sits down with principal investigator Prof Stefan James (Uppsala University, SE) to discuss results of the SWEDEGRAFT trial (NCT03501303; Uppsala University).
The SWEDEGRAFT trial is a prospective, binational, multicenter, open-label, registry-based study comparing the non-touch and conventional vein graft techniques in patients undergoing first-time CABG surgery. A total of 902 patients aged up to 80 years were randomized to either group. The primary outcome is graft failure, defined as SVG occlusion or stenosis greater than 50% on coronary computed tomography angiography (CCTA), percutaneous intervention to a vein graft, or death within two years post-CABG.
The investigators found that no-touch vein harvest technique was not superior to the conventional technique in preventing vein graft failure or improving mid-term clinical outcomes in patients undergoing non-emergent CABG. However, it was associated with an increased risk of early leg wound complications and residual wound symptoms.
Recorded on-site at ESC Congress 2024, London.
Editors: Jordan Rance and Mirjam Boros.
Videographers: Mike Knight, Dan Brent, Oliver Miles, Tom Green, David-Ben-Harosh.
Support: This is an independent interview produced by Radcliffe Cardiology.
Faculty Biographies
Harriette Van Spall
Associate Professor of Medicine, Director of E-Health and Virtual Care
Dr Harriette Van Spall is an Associate Professor of Medicine and cardiologist and serves as Director of E-Health at McMaster University, Canada. She completed her medical and postgraduate clinical training at the University of Toronto and earned a Master of Public Health degree at Harvard University, US. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.
She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals. She is an invited speaker, media correspondent, and editorial board member active in peer review at several high-impact medications journals and grant funding agencies, including Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.
Dr Van Spall is an Editorial Board…
Stefan James
Professor of Cardiology
Prof Stefan James is Professor of Cardiology at Uppsala University, Scientific Director of Uppsala Clinical Research Center and a senior Interventional Cardiologist at Uppsala University Hospital in Sweden. He is the president of the Swedish society of Cardiology and a Fellow of the ESC.
He graduated from Uppsala University Medical School and completed specialist training in Uppsala. He has previously held positions at the Karolinska Hospital, the University Hospital Örebro and Duke Clinical Research Institute, Duke University.
Comments